DRUG
Bright Minds·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
DRUG fundamentals
Bright Minds (DRUG) released its earnings on Aug 11, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.292093 (YoY 0.00%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.292093
0.00%
Report date
Aug 11, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Bright Minds (DRUG) key financial stats and ratios, covering profitability, financial health, and leverage.
Bright Minds (DRUG)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bright Minds (DRUG)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bright Minds (DRUG)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bright Minds (DRUG) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bright Minds (DRUG) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Bright Minds do and what are its main business segments?What is the revenue and EPS growth rate for Bright Minds year over year?What is Bright Minds's gross profit margin?What factors drove the changes in Bright Minds's revenue and profit?What is Bright Minds's latest dividend and current dividend yield?What is the market's earnings forecast for Bright Minds next quarter?What were the key takeaways from Bright Minds's earnings call?What were the key takeaways from Bright Minds’s earnings call?
